MiR-150-5p also presented the highest number of associations with the clinical parameters analyzed; its down-regulation was associated with larger tumor size, high expression levels of the p53 protein, increased breast cancer recurrence, presence of distant metastasis, and patients’ deceased status. Here, TP53 is linked to breast cancer.